Enovis Completes Dr. Comfort Footcare Solutions Sale for Up to $60 Million

Enovis has completed the sale of its Dr. Comfort Footcare Solutions business to Promus Equity Partners for up to $60 million. The deal includes an upfront payment of $45 million and up to $15 million payable upon certain milestones. Enovis CEO Damien McDonald stated that the sale sharpens the company's focus on core strengths and positions it to expand margins, enhance profitability, and accelerate debt reduction.

Enovis (NYSE: ENOV) has completed the sale of its Dr. Comfort Footcare Solutions business to Promus Equity Partners for up to $60 million. The deal includes an upfront payment of $45 million and up to $15 million payable upon the achievement of certain milestones Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[1]Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[2].

The sale represents a strategic move for Enovis, allowing the company to focus on its core strengths and market leadership in the Prevention & Recovery franchise. Damien McDonald, Enovis' Chief Executive Officer, stated that the transaction will enable Enovis to expand margins, enhance profitability, and accelerate debt reduction, further strengthening its role as a focused medical technology innovator Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[1]Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[2].

Enovis will provide additional strategic commentary on the transaction during its third quarter results call on November 6, 2025, at 8:30 am ET. Investors can access the live webcast via a link on the Enovis website Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[1]Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[2].

Promus Equity Partners, a multi-family asset management firm based in Chicago with approximately $2.7 billion under management, will be acquiring the Dr. Comfort business. The firm is excited to build upon the long heritage of Dr. Comfort in serving clinicians, channel partners, and patients with quality products and exceptional service Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[1]Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[2].

Enovis is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[1]Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million^[2].